Long noncoding RNAs-related diseases, cancers, and drugs.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 3690748)

Published in ScientificWorldJournal on June 06, 2013

Authors

Jen-Yang Tang1, Jin-Ching Lee, Yung-Ting Chang, Ming-Feng Hou, Hurng-Wern Huang, Chih-Chuang Liaw, Hsueh-Wei Chang

Author Affiliations

1: Department of Radiation Oncology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Articles citing this

A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer. J Transl Med (2015) 1.21

lncRNASNP: a database of SNPs in lncRNAs and their potential functions in human and mouse. Nucleic Acids Res (2014) 1.03

The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). Int J Oncol (2014) 0.93

Long non-coding RNA deregulation in tongue squamous cell carcinoma. Biomed Res Int (2014) 0.91

Long non-coding RNA profiling in laryngeal squamous cell carcinoma and its clinical significance: potential biomarkers for LSCC. PLoS One (2014) 0.90

Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer. Cancer Sci (2015) 0.87

Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer. World J Surg Oncol (2015) 0.78

Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813. Int J Clin Exp Pathol (2015) 0.78

Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer. PLoS One (2017) 0.78

Genome-wide identification and characterization of long non-coding RNAs in developmental skeletal muscle of fetal goat. BMC Genomics (2016) 0.77

Long noncoding RNAs as metazoan developmental regulators. Chromosome Res (2013) 0.76

Genetic Background Modulates lncRNA-Coordinated Tissue Response to Low Dose Ionizing Radiation. Int J Genomics (2015) 0.75

Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations. Oncotarget (2017) 0.75

LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation. Mol Cancer (2017) 0.75

Co-Expression Network Analysis of Fbxw7-Associated LncRNAs Reveals Their Functions in Radiation-Induced Thymic Lymphoma. Insights Cancer Res (2016) 0.75

Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis. World J Surg Oncol (2017) 0.75

Articles cited by this

(truncated to the top 100)

The transcriptional landscape of the mammalian genome. Science (2005) 37.63

Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56

Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55

Long noncoding RNA as modular scaffold of histone modification complexes. Science (2010) 15.23

Genome regulation by long noncoding RNAs. Annu Rev Biochem (2012) 11.70

Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA (2004) 11.52

Molecular mechanisms of long noncoding RNAs. Mol Cell (2011) 11.44

Long noncoding RNAs and human disease. Trends Cell Biol (2011) 7.59

The functional role of long non-coding RNA in human carcinomas. Mol Cancer (2011) 6.37

The emergence of lncRNAs in cancer biology. Cancer Discov (2011) 6.32

lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature (2011) 5.42

Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene (2010) 4.81

Epigenetic regulation by long noncoding RNAs. Science (2012) 4.74

Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology (2006) 4.70

CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res (2010) 4.68

lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res (2010) 4.49

No-nonsense functions for long noncoding RNAs. Cell (2011) 4.23

Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol (2011) 3.24

Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology (2011) 3.05

Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett (2013) 2.99

NONCODE v3.0: integrative annotation of long noncoding RNAs. Nucleic Acids Res (2011) 2.82

Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells. Proc Natl Acad Sci U S A (2013) 2.75

LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res (2012) 2.73

MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett (2010) 2.67

Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature (2012) 2.63

MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol (2011) 2.59

Long non-coding RNAs in nervous system function and disease. Brain Res (2010) 2.53

The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res (2011) 2.52

Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci (2012) 2.52

Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res (2012) 2.47

Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis (2009) 2.45

LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res (2012) 2.40

A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell (2012) 2.29

Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J (2012) 2.26

NRED: a database of long noncoding RNA expression. Nucleic Acids Res (2008) 2.21

UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett (2008) 2.14

ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic Acids Res (2012) 2.11

Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev (2011) 2.06

Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl (2008) 2.00

Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst (2012) 2.00

DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res (2012) 1.94

Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol (2006) 1.90

Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci (2013) 1.88

Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Rep (2012) 1.82

Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep (2012) 1.81

Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res (2010) 1.76

miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer (2012) 1.72

Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells. Epigenetics (2009) 1.71

Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis (2012) 1.70

NONCODE v2.0: decoding the non-coding. Nucleic Acids Res (2007) 1.69

Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One (2013) 1.68

The 2013 Nucleic Acids Research Database Issue and the online molecular biology database collection. Nucleic Acids Res (2012) 1.66

Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene (2012) 1.64

DNA methyltransferases, DNA damage repair, and cancer. Adv Exp Med Biol (2013) 1.57

Long non-coding RNAs and enhancers. Curr Opin Genet Dev (2011) 1.52

Long non-coding RNA in cancer. Int J Mol Sci (2013) 1.52

Long non-coding RNAs in Huntington's disease neurodegeneration. Neurobiol Dis (2011) 1.51

Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal (2013) 1.50

Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology (2013) 1.49

ncFANs: a web server for functional annotation of long non-coding RNAs. Nucleic Acids Res (2011) 1.46

CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment. Front Genet (2012) 1.45

Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol (2012) 1.45

Effect of 5-aza-2'-deoxycytidine on methylation of the putative imprinted control region of H19 during the in vitro development of vitrified bovine two-cell embryos. Fertil Steril (2012) 1.41

Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/β-catenin signaling. Hepatology (2013) 1.40

LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol (2012) 1.40

Long non-coding RNA modifies chromatin: epigenetic silencing by long non-coding RNAs. Bioessays (2011) 1.39

Naming 'junk': human non-protein coding RNA (ncRNA) gene nomenclature. Hum Genomics (2011) 1.39

Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst (2013) 1.37

Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis (2011) 1.37

Long non-coding RNAs and human disease. Biochem Soc Trans (2012) 1.35

A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One (2012) 1.33

Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol (2012) 1.30

iSeeRNA: identification of long intergenic non-coding RNA transcripts from transcriptome sequencing data. BMC Genomics (2013) 1.21

Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression. Biochem Biophys Res Commun (2013) 1.21

Potential roles of microRNAs in regulating long intergenic noncoding RNAs. BMC Med Genomics (2013) 1.19

Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J (2012) 1.19

Identification of long stress-induced non-coding transcripts that have altered expression in cancer. Genomics (2010) 1.17

Kcnq1ot1: a chromatin regulatory RNA. Semin Cell Dev Biol (2011) 1.16

Association of birth weight with polymorphisms in the IGF2, H19, and IGF2R genes. Pediatr Res (2010) 1.13

Polymorphisms in the H19 gene and the risk of bladder cancer. Eur Urol (2008) 1.12

Long antisense non-coding RNAs and their role in transcription and oncogenesis. Cell Cycle (2010) 1.11

Non-coding RNAs as regulators of mammary development and breast cancer. J Mammary Gland Biol Neoplasia (2012) 1.11

Long noncoding RNA-mediated maintenance of DNA methylation and transcriptional gene silencing. Development (2012) 1.11

Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications. Genet Res Int (2012) 1.03

Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells. Biochim Biophys Acta (2012) 1.00

Noncoding transcripts in sense and antisense orientation regulate the epigenetic state of ribosomal RNA genes. Cold Spring Harb Symp Quant Biol (2011) 1.00

Association between lncrna PCGEM1 polymorphisms and prostate cancer risk. Prostate Cancer Prostatic Dis (2013) 1.00

Molecular mechanisms and function prediction of long noncoding RNA. ScientificWorldJournal (2012) 0.98

DNA methylation as a target of epigenetic therapeutics in cancer. Anticancer Agents Med Chem (2013) 0.92

Bioinformatics tools and novel challenges in long non-coding RNAs (lncRNAs) functional analysis. Int J Mol Sci (2011) 0.92

Cigarette smoke exposure-associated alterations to non-coding RNA. Front Genet (2012) 0.91

Long non-coding RNAs coordinate cellular responses to stress. Wiley Interdiscip Rev RNA (2012) 0.90

Characterization of a carcinogenesis-associated long non-coding RNA. RNA Biol (2012) 0.90

MALAT-1, a non protein-coding RNA is upregulated in the cerebellum, hippocampus and brain stem of human alcoholics. Alcohol (2012) 0.89

A new 'Linc' between noncoding RNAs and blood development. Genes Dev (2011) 0.89

Additive effect of ANRIL and BRAP polymorphisms on ankle-brachial index in a Taiwanese population. Circ J (2011) 0.88

Long non-coding RNAs involved in cancer development and cell fate determination. Curr Drug Targets (2012) 0.86

Recent progress in the study of methylated tumor suppressor genes in gastric cancer. Chin J Cancer (2011) 0.82

A novel molecular mechanism in human genetic disease: a DNA repeat-derived lncRNA. RNA Biol (2012) 0.82

Association of ANRIL polymorphism (rs1333049:C>G) with myocardial infarction and its pharmacogenomic role in hypercholesterolemia. Gene (2012) 0.82

Articles by these authors

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet (2013) 7.25

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72

Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis (2005) 2.31

Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol (2002) 2.18

Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett (2005) 2.13

Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet (2010) 1.98

Improved binary PSO for feature selection using gene expression data. Comput Biol Chem (2007) 1.51

Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan. Vaccine (2006) 1.48

Antiproliferative activity of aucubin is through cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol (2008) 1.42

The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology (2002) 1.40

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet (2013) 1.39

Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet (2013) 1.38

An improved PSO algorithm for generating protective SNP barcodes in breast cancer. PLoS One (2012) 1.29

Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med (2008) 1.29

11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat (2012) 1.26

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.23

Private doctors' practices, knowledge, and attitude to reporting of communicable diseases: a national survey in Taiwan. BMC Infect Dis (2009) 1.20

Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties. Cancer Cell Int (2013) 1.19

Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy. Radiother Oncol (2009) 1.18

Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS (2009) 1.16

Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. Biochim Biophys Acta (2013) 1.15

Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22. Int J Radiat Oncol Biol Phys (2012) 1.15

International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer (2011) 1.14

Isolation and identification of mesenchymal stem cells from human lipoma tissue. Biochem Biophys Res Commun (2007) 1.14

Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13

Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J Biomed Sci (2004) 1.13

Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers (2009) 1.13

Anti-proliferative effect of methanolic extract of Gracilaria tenuistipitata on oral cancer cells involves apoptosis, DNA damage, and oxidative stress. BMC Complement Altern Med (2012) 1.12

Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells. J Biol Chem (2008) 1.12

Involvement of store-operated calcium signaling in EGF-mediated COX-2 gene activation in cancer cells. Cell Signal (2011) 1.09

Antitumor agents. 228. five new agarofurans, Reissantins A-E, and cytotoxic principles from Reissantia buchananii. J Nat Prod (2003) 1.07

AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model. Mol Cancer Ther (2006) 1.07

Association of ORAI1 haplotypes with the risk of HLA-B27 positive ankylosing spondylitis. PLoS One (2011) 1.07

Quality of life, depression, and stress in breast cancer women outpatients receiving active therapy in Taiwan. Psychiatry Clin Neurosci (2006) 1.07

Influenza A (H(1)N(1)) Antiviral and Cytotoxic Agents from Ferula assa-foetida. J Nat Prod (2009) 1.06

4beta-Hydroxywithanolide E from Physalis peruviana (golden berry) inhibits growth of human lung cancer cells through DNA damage, apoptosis and G2/M arrest. BMC Cancer (2010) 1.06

De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva. J Hum Genet (2006) 1.05

Acetogenins as selective inhibitors of the human ovarian 1A9 tumor cell line. J Med Chem (2003) 1.05

MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis (2012) 1.05

Antiproliferation and induction of apoptosis in Ca9-22 oral cancer cells by ethanolic extract of Gracilaria tenuistipitata. Molecules (2012) 1.05

MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncol Rep (2009) 1.04

Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Virchows Arch (2003) 1.03

Antiproliferative effects of goniothalamin on Ca9-22 oral cancer cells through apoptosis, DNA damage and ROS induction. Mutat Res (2012) 1.03

Chaotic particle swarm optimization for detecting SNP-SNP interactions for CXCL12-related genes in breast cancer prevention. Eur J Cancer Prev (2012) 1.02

p38 MAPK and NF-kappaB pathways are involved in naphtho[1,2-b] furan-4,5-dione induced anti-proliferation and apoptosis of human hepatoma cells. Cancer Lett (2010) 1.01

Fascin protein is critical for transforming growth factor β protein-induced invasion and filopodia formation in spindle-shaped tumor cells. J Biol Chem (2011) 1.00

Goniothalamin inhibits growth of human lung cancer cells through DNA damage, apoptosis, and reduced migration ability. J Agric Food Chem (2011) 1.00

Resistin expression in breast cancer tissue as a marker of prognosis and hormone therapy stratification. Gynecol Oncol (2012) 0.99

Disturbance of circadian gene expression in breast cancer. Virchows Arch (2009) 0.99

Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta (2005) 0.99

Evaluation of breast cancer susceptibility using improved genetic algorithms to generate genotype SNP barcodes. IEEE/ACM Trans Comput Biol Bioinform (2013) 0.98

Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol (2007) 0.98

STAT3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma. Int J Cancer (2006) 0.98

Fern plant-derived protoapigenone leads to DNA damage, apoptosis, and G(2)/m arrest in lung cancer cell line H1299. DNA Cell Biol (2009) 0.97

Increasing CD44+/CD24(-) tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis. Mol Cancer (2010) 0.97

Obtusilactone A and (-)-sesamin induce apoptosis in human lung cancer cells by inhibiting mitochondrial Lon protease and activating DNA damage checkpoints. Cancer Sci (2010) 0.97

Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis (2009) 0.97

New cytotoxic flavonoids from Thelypteris torresiana. Planta Med (2005) 0.96

Computational analysis of simulated SNP interactions between 26 growth factor-related genes in a breast cancer association study. OMICS (2011) 0.96

Aqueous extracts of the edible Gracilaria tenuistipitata are protective against H₂O₂-induced DNA damage, growth inhibition, and cell cycle arrest. Molecules (2012) 0.95

Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer. PLoS One (2013) 0.95

(-)-Anonaine induces DNA damage and inhibits growth and migration of human lung carcinoma h1299 cells. J Agric Food Chem (2011) 0.94

Single nucleotide polymorphism barcoding to evaluate oral cancer risk using odds ratio-based genetic algorithms. Kaohsiung J Med Sci (2012) 0.94

The association between lipid profiles and breast cancer among Taiwanese women. Clin Chem Lab Med (2007) 0.94

Combination of multiple mRNA markers (PTTG1, Survivin, UbcH10 and TK1) in the diagnosis of Taiwanese patients with breast cancer by membrane array. Oncology (2007) 0.94

Anticancer drugs for the modulation of endoplasmic reticulum stress and oxidative stress. Tumour Biol (2015) 0.94

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. Gut (2012) 0.93

Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility. J Biomed Sci (2006) 0.93

4-Shogaol, an active constituent of dietary ginger, inhibits metastasis of MDA-MB-231 human breast adenocarcinoma cells by decreasing the repression of NF-κB/Snail on RKIP. J Agric Food Chem (2012) 0.93

Glabridin, an isoflavan from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway. Mol Nutr Food Res (2011) 0.92

Flavokawain B inhibits growth of human squamous carcinoma cells: Involvement of apoptosis and cell cycle dysregulation in vitro and in vivo. J Nutr Biochem (2011) 0.92

Golden berry-derived 4β-hydroxywithanolide E for selectively killing oral cancer cells by generating ROS, DNA damage, and apoptotic pathways. PLoS One (2013) 0.92

Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer. Neoplasia (2010) 0.92

Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu. Mod Pathol (2008) 0.91

Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway. Food Chem Toxicol (2010) 0.91

Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese. Breast Cancer Res Treat (2006) 0.91

SNP combinations in chromosome-wide genes are associated with bone mineral density in Taiwanese women. Chin J Physiol (2008) 0.91

Novel generating protective single nucleotide polymorphism barcode for breast cancer using particle swarm optimization. Cancer Epidemiol (2009) 0.91

Differential gene expression of bone morphogenetic protein 15 and growth differentiation factor 9 during in vitro maturation of porcine oocytes and early embryos. Anim Reprod Sci (2006) 0.91

The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse. PLoS One (2013) 0.91

A study of glutathione status in the blood and tissues of patients with breast cancer. Cell Biochem Funct (2006) 0.90

In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a noninhibitory protease substrate. Clin Cancer Res (2011) 0.90

Selective cytotoxicity of squamocin on T24 bladder cancer cells at the S-phase via a Bax-, Bad-, and caspase-3-related pathways. Life Sci (2005) 0.90

The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012. Gastroenterol Res Pract (2012) 0.90

The Antitumor Activity of Antrodia camphorata in Melanoma Cells: Modulation of Wnt/β-Catenin Signaling Pathways. Evid Based Complement Alternat Med (2012) 0.90

Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy. Pharmacogenet Genomics (2011) 0.90

Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Sp1 in breast cancer cells. J Cell Physiol (2013) 0.89

A retrospective study of the safety and efficacy of a first-line treatment with modified FOLFOX-4 in unresectable advanced or recurrent gastric cancer patients. Chemotherapy (2013) 0.89